Note from Mag I Henninger re Tiseel and Virus inactivated blood products. Issues related to the product license application products not virus-inactivated will not be used after April 1985 and that data for Kryobulin TIM 2 should be submitted to the authorities in order to maintain market position as is the licence application for Feiba.